CARLSBAD, Calif. – SynergEyes, Inc., the manufacturer of hybrid contact lens technology, reported that the Food and Drug Administration (FDA) has approved the company’s application for a next generation silicone hydrogel hybrid contact lens.

The new hybrid platform is cleared for use in the correction of hyperopic, myopic and astigmatic refractive error including presbyopia, in aphakic and non-aphakic non-diseased eyes. The lenses are indicated for daily wear for the correction of up to +20.00 and -20.00D in eyes with astigmatism up to +6.00D.

SynergEyes said it will market the new hybrid technology as two contact lens products: Duette hybrid contact lenses for astigmatism and Duette Multifocal for presbyopia.

“Duette hybrid contact lenses represent a significant advancement in the contact lens industry and give eye care professionals an innovative product that delivers an unprecedented combination of visual acuity and comfort to a broad range of patients,” said Jim Ham, CEO for SynergEyes, Inc. “Our next generation products will re-define state-of-the art in the vision correction industry.”

Duette hybrid contact lenses for astigmatism are currently available in limited release in select practices in the U.S. A nationwide launch is planned for early 2011. In addition, Duette Multifocal will be available in limited release in early 2011.